Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.00 from other evidence | 0.00 |
| cell type Human Protein Atlas | cell type enhanced, including brain inhibitory neurons; strongest in platelets | 0.75 |
| chemistry Open Targets | reachable by antibody | 0.45 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 72 | 0.91 |
| pathways Reactome | 1 pathway; mostly energy | 0.60 |
No case: the score is under the bar. Receipt 13229
Sealed predictions
- LRP12 in dopamine neurons, braak+0.54 (p 0.135) → +0.35 (p 0.349)receipt 13235
Swarm cases
receipt 13235: LRP12 in dopamine neurons, braak
- power
- full sample +0.34 (p 0.167, n 18), 95% CI -0.15 to +0.70. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.33 (p 0.182, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.36 (p 0.137, n 18). could be the mix.
- skeptic
- leave-one-out range +0.26 to +0.51, sign flips 0; without severely affected donors +0.34 (p 0.167, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for LRP12 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts